MiR-219a-5p enhances cisplatin sensitivity of human non-small cell lung cancer by targeting FGF9

In conclusion, this study demonstrated miR-219a-5p plays a crucial role in the development of acquired drug resistance to DDP in NSCLC cells by targeting FGF9 and might be a therapeutic target for DDP resistance in clinical practice.
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research